This inventor holds 1 USPTO granted patent. Top assignee: Zhejiang Charioteer Pharmaceutical Co., Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations of Tian Chen in Pharmaceutical Chemistry
Introduction
Tian Chen is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of acyclovir 2/3 hydrate. His innovative methods have implications for industrial production and the pharmaceutical industry.
Latest Patents
Tian Chen holds a patent for a method of preparing acyclovir 2/3 hydrate. The process involves mixing acyclovir with water at a weight ratio of 1:5 to 50, dissolving the mixture at temperatures between 50 to 100 degrees Celsius, filtering the solution, and cooling the filtrate to precipitate crystals. The crystals are then collected through filtration and dried at temperatures ranging from 0 to 150 degrees Celsius for a duration of 0.5 to 24 hours. This method is not only simple but also suitable for industrial production, yielding a product with a good and stable crystal form. He has 1 patent to his name.
Career Highlights
Tian Chen is associated with Zhejiang Charioteer Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovations. His work has been instrumental in enhancing the efficiency and effectiveness of drug production processes.
Collaborations
Tian Chen collaborates with talented individuals such as Tong Pu and Yi Fan, contributing to a dynamic work environment that fosters innovation and development in pharmaceutical research.
Conclusion
Tian Chen's contributions to the field of pharmaceutical chemistry, particularly through his patent for preparing acyclovir 2/3 hydrate, highlight his role as an influential inventor. His work not only advances scientific knowledge but also has practical applications in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile